The Cooper Companies, Inc.

NasdaqGS:COO

Sector

🏥 Health Care

Industries

🕶 Eyewear

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 14.19 B

Share Price

USD 71.14

Avg Daily Volume

2,397,385

Change (1 day)

2.08%

Change (1 year)

-18.81%

Change (YTD)

-22.61%

The Cooper Companies, Inc. Net Income for the Trailing 12 Months (TTM) ending April 30, 2025: USD 414.20 M

The Cooper Companies, Inc. Net Income is USD 414.20 M for the Trailing 12 Months (TTM) ending April 30, 2025, a 21.86% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

The Cooper Companies, Inc. Net Income for the Trailing 12 Months (TTM) ending April 30, 2024 was USD 339.90 M, a 17.86% change year over year.
The Cooper Companies, Inc. Net Income for the Trailing 12 Months (TTM) ending April 30, 2023 was USD 288.40 M, a -69.58% change year over year.
The Cooper Companies, Inc. Net Income for the Trailing 12 Months (TTM) ending April 30, 2022 was USD 948.00 M, a -59.75% change year over year.
The Cooper Companies, Inc. Net Income for the Trailing 12 Months (TTM) ending April 30, 2021 was USD 2.35 B, a 586.39% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Selling, General, and Administrative Expenses (SG&A)

NasdaqGS: COO

The Cooper Companies, Inc.

CEO	Mr. Albert G. White III
IPO Date	Jan. 21, 1983
Location	United States
Headquarters	6101 Bollinger Canyon Road
Employees	16,000
Sector	🏥 Health Care
Industries Eyewear 🩺 Medical Instruments 💻 Telehealth

Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.